KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Return on Sales: 2010-2024

Historic Return on Sales for TherapeuticsMD (TXMD) over the last 15 years, with Dec 2024 value amounting to 0.07%.

  • TherapeuticsMD's Return on Sales fell 33.00% to 0.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.08%, marking a year-over-year decrease of 33.00%. This contributed to the annual value of 0.07% for FY2024, which is 206.00% up from last year.
  • According to the latest figures from FY2024, TherapeuticsMD's Return on Sales is 0.07%, which was up 103.76% from -1.98% recorded in FY2023.
  • In the past 5 years, TherapeuticsMD's Return on Sales registered a high of 1.59% during FY2022, and its lowest value of -36.19% during FY2021.
  • Moreover, its 3-year median value for Return on Sales was 0.07% (2024), whereas its average is -0.11%.
  • In the last 5 years, TherapeuticsMD's Return on Sales slumped by 3,336bps in 2021 and then soared by 3,777bps in 2022.
  • Yearly analysis of 5 years shows TherapeuticsMD's Return on Sales stood at -2.83% in 2020, then crashed by 3,336bps to -36.19% in 2021, then spiked by 3,777bps to 1.59% in 2022, then crashed by 357bps to -1.98% in 2023, then soared by 206bps to 0.07% in 2024.